EG19170A - A process for preparing of ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2- hydroxyacids - Google Patents

A process for preparing of ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2- hydroxyacids

Info

Publication number
EG19170A
EG19170A EG6290A EG6290A EG19170A EG 19170 A EG19170 A EG 19170A EG 6290 A EG6290 A EG 6290A EG 6290 A EG6290 A EG 6290A EG 19170 A EG19170 A EG 19170A
Authority
EG
Egypt
Prior art keywords
hydroxyacids
indazole
hydroxymethyl
ethers
benzyl
Prior art date
Application number
EG6290A
Other languages
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of EG19170A publication Critical patent/EG19170A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
EG6290A 1989-02-07 1990-02-06 A process for preparing of ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2- hydroxyacids EG19170A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
EG19170A true EG19170A (en) 1994-11-30

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
EG6290A EG19170A (en) 1989-02-07 1990-02-06 A process for preparing of ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2- hydroxyacids

Country Status (36)

Country Link
US (2) US4999367A (sh)
EP (1) EP0382276B1 (sh)
JP (1) JP2870925B2 (sh)
KR (1) KR0145525B1 (sh)
CN (2) CN1046505C (sh)
AR (1) AR247386A1 (sh)
AT (1) ATE127115T1 (sh)
AU (1) AU624895B2 (sh)
BG (1) BG50273A3 (sh)
CA (1) CA2009503C (sh)
CZ (1) CZ280121B6 (sh)
DD (2) DD291995A5 (sh)
DE (2) DE382276T1 (sh)
DK (1) DK0382276T3 (sh)
EG (1) EG19170A (sh)
ES (1) ES2020171T3 (sh)
FI (1) FI102678B (sh)
GE (1) GEP19971030B (sh)
GR (2) GR910300073T1 (sh)
HU (1) HU204793B (sh)
IL (1) IL93132A (sh)
IN (1) IN170957B (sh)
IT (1) IT1230441B (sh)
LT (1) LT3604B (sh)
LV (1) LV10612B (sh)
NZ (1) NZ232258A (sh)
PE (1) PE25091A1 (sh)
PH (1) PH26552A (sh)
PL (2) PL163730B1 (sh)
PT (1) PT93067B (sh)
RO (1) RO106252B1 (sh)
RU (3) RU2066318C1 (sh)
SK (1) SK278441B6 (sh)
UA (1) UA26852C2 (sh)
YU (1) YU47943B (sh)
ZA (1) ZA90644B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
PL2254869T3 (pl) * 2008-03-07 2017-10-31 Acraf Nowe pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób bazujących na ekspresji CX3CR1 i p40
HUE026910T2 (en) 2008-03-07 2016-07-28 Acraf 1-Benzyl-3-hydroxymethylindazole derivatives and their use in the treatment of MCP-1 and CX3CR1 expression-based diseases
PL2262778T3 (pl) 2008-03-07 2020-02-28 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CXCR1 i p40
KR101736301B1 (ko) * 2009-08-03 2017-05-29 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸-1h-인다졸 및 이의 유도체 및 필요한 마그네슘 중간체들의 제조 방법
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
AU2013255050B2 (en) 2012-05-01 2016-07-28 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
AU2013261718B2 (en) 2012-05-18 2017-10-19 Sanofi Pyrazole derivatives and their use as LPAR5 antagonists
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
ZA90644B (en) 1991-01-30
PT93067B (pt) 1995-12-29
IT1230441B (it) 1991-10-23
CN1046505C (zh) 1999-11-17
YU47943B (sh) 1996-07-24
YU20690A (sh) 1992-07-20
HUT53088A (en) 1990-09-28
FI900577A0 (fi) 1990-02-06
CN1034016C (zh) 1997-02-12
CZ56390A3 (en) 1995-06-14
IL93132A0 (en) 1990-11-05
HU204793B (en) 1992-02-28
HU900689D0 (en) 1990-04-28
LV10612A (lv) 1995-04-20
RU2055071C1 (ru) 1996-02-27
EP0382276B1 (en) 1995-08-30
KR900012913A (ko) 1990-09-03
NZ232258A (en) 1991-06-25
PE25091A1 (es) 1991-08-17
PL163730B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
DD291995A5 (de) 1991-07-18
GR3018165T3 (en) 1996-02-29
JP2870925B2 (ja) 1999-03-17
ES2020171A4 (es) 1991-08-01
EP0382276A3 (en) 1990-12-12
CA2009503C (en) 2000-04-11
DD295363A5 (de) 1991-10-31
PL163720B1 (pl) 1994-04-29
AR247386A1 (es) 1994-12-29
CZ280121B6 (cs) 1995-11-15
UA26852C2 (uk) 1999-12-29
CA2009503A1 (en) 1990-08-07
KR0145525B1 (ko) 1998-08-17
CN1044810A (zh) 1990-08-22
SK56390A3 (en) 1997-05-07
CN1088201A (zh) 1994-06-22
AU624895B2 (en) 1992-06-25
IL93132A (en) 1994-05-30
PT93067A (pt) 1990-08-31
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
FI102678B (fi) 1999-01-29
ATE127115T1 (de) 1995-09-15
EP0382276A2 (en) 1990-08-16
US4999367A (en) 1991-03-12
DE382276T1 (de) 1991-11-28
ES2020171T3 (es) 1995-12-01
DK0382276T3 (da) 1996-01-15
US5112986A (en) 1992-05-12
GR910300073T1 (en) 1991-11-15
BG50273A3 (en) 1992-06-15
LT3604B (en) 1995-12-27
LTIP872A (en) 1995-03-27
IN170957B (sh) 1992-06-20
LV10612B (en) 1995-08-20
SK278441B6 (en) 1997-05-07
RU2044729C1 (ru) 1995-09-27
AU4906690A (en) 1990-08-16
IT8947620A0 (it) 1989-02-07
RO106252B1 (ro) 1993-03-31
DE69021902D1 (de) 1995-10-05
PH26552A (en) 1992-08-19
RU2066318C1 (ru) 1996-09-10
DE69021902T2 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
EG19170A (en) A process for preparing of ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2- hydroxyacids
ZA906536B (en) Process for the preparation of a polyefin
YU67290A (en) Process for preparing cephodizim-disodium
GB2225322B (en) A process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
EP0262744A3 (en) A process for preparing 3-alkoxymethylcephalosphorins
IL88943A0 (en) Process for preparing 1-alkyl-5-nitroimidazoles
DE3566396D1 (en) Process for preparing ethers
GB2216519B (en) Process for preparing n-sulphonyl-ureas
KR960009690B1 (en) Process for preparing polyarylenethioether
GB2222403B (en) Process for preparing 2-methoxyisobutylisonitrile
HUT43564A (en) Process for preparing novel monocyclic ethers
GR871012B (en) Process for preparing a mercaptoacylproline
ZA878326B (en) A process for preparing herbicidal diphenyc ether derivatives
ZA905595B (en) A novel process for the preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
EP0420556A3 (en) Process for the preparation of 4-bromo-3-alkylphenyl ethers
ZA895008B (en) Process for preparing perfluoro-(2-bromoethyl-vinyl-ether)
YU146589A (en) Process for preparing new alylaminoethyl-azoles
GB2250741B (en) A process for preparing alkaloids
EP0433888A3 (en) Process for preparing polyalkylenglycolbisethers
AR243739A1 (es) Procedimiento de preparacion de un agente aromatizante.
PT86146A (en) Process for preparing substituted phenylbenzyl-(dimethylcyclopropylmethyl)ethers
YU87489A (en) Process for preparing felodipyn
IE890678L (en) Process for preparing n-sulphonyl-ureas
EP0405517A3 (en) Process for preparing bromodifluoroacetylfluoride
KR0142108B1 (en) Process for preparing 4-demethoxydaunomycinone